Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Data ; 11(1): 136, 2024 Jan 26.
Article in English | MEDLINE | ID: mdl-38278822

ABSTRACT

Diffuse reflectance spectroscopy (DRS) has been extensively studied in both preclinical and clinical settings for multiple applications, notably as a minimally invasive diagnostic tool for tissue identification and disease delineation. In this study, extended-wavelength DRS (EWDRS) measurements of ex vivo tissues ranging from ultraviolet through visible to the short-wave infrared region (355-1919 nm) are presented in two datasets. The first dataset contains labelled EWDRS measurements collected from bone cement samples and ovine specimens including 10 tissue types commonly encountered in orthopedic surgeries for data curation purposes. The other dataset includes labelled EWDRS measurements of primarily bone structures at different depths during stepwise drilling into intact porcine skulls until plunging into the cranial cavity. The raw data with code for pre-processing and calibration is publicly available for reuse on figshare. The datasets can be utilized not only for exploratory purposes in machine learning model construction, but also for knowledge discovery in the orthopedic domain to identify important features for surgical guidance, extract physiological parameters and provide diagnostic insights.


Subject(s)
Bone and Bones , Machine Learning , Animals , Sheep , Spectrum Analysis/methods , Swine , Orthopedic Procedures
2.
J Biomed Opt ; 28(12): 121207, 2023 12.
Article in English | MEDLINE | ID: mdl-37674977

ABSTRACT

Significance: Wavelength selection from a large diffuse reflectance spectroscopy (DRS) dataset enables removal of spectral multicollinearity and thus leads to improved understanding of the feature domain. Feature selection (FS) frameworks are essential to discover the optimal wavelengths for tissue differentiation in DRS-based measurements, which can facilitate the development of compact multispectral optical systems with suitable illumination wavelengths for clinical translation. Aim: The aim was to develop an FS methodology to determine wavelengths with optimal discriminative power for orthopedic applications, while providing the frameworks for adaptation to other clinical scenarios. Approach: An ensemble framework for FS was developed, validated, and compared with frameworks incorporating conventional algorithms, including principal component analysis (PCA), linear discriminant analysis (LDA), and backward interval partial least squares (biPLS). Results: Via the one-versus-rest binary classification approach, a feature subset of 10 wavelengths was selected from each framework yielding comparable balanced accuracy scores (PCA: 94.8±3.47%, LDA: 98.2±2.02%, biPLS: 95.8±3.04%, and ensemble: 95.8±3.16%) to those of using all features (100%) for cortical bone versus the rest class labels. One hundred percent balanced accuracy scores were generated for bone cement versus the rest. Different feature subsets achieving similar outcomes could be identified due to spectral multicollinearity. Conclusions: Wavelength selection frameworks provide a means to explore domain knowledge and discover important contributors to classification in spectroscopy. The ensemble framework generated a model with improved interpretability and preserved physical interpretation, which serves as the basis to determine illumination wavelengths in optical instrumentation design.


Subject(s)
Optical Imaging , Orthopedic Procedures , Spectrum Analysis , Algorithms , Discriminant Analysis , Spectrum Analysis/methods , Optical Imaging/instrumentation , Principal Component Analysis
3.
J Biomed Opt ; 27(2)2022 02.
Article in English | MEDLINE | ID: mdl-35106981

ABSTRACT

SIGNIFICANCE: Our work demonstrates in preclinical models that continuous-wave transrectal diffuse optical tomography (TRDOT) can be used to accurately monitor photothermal therapy (PTT) and, in particular, the progression of the photocoagulation boundary toward the rectum. When used in patients, this should prevent rectal damage during PTT, thereby achieving maximum treatment efficacy while ensuring safety, using a technology platform suitable for wide dissemination. AIM: We aim to validate that TRDOT measurements analyzed using a shape-based image-reconstruction algorithm (SBDOT) allow localization of the photocoagulation boundary during PTT within ±1 mm toward the rectum in the transverse plane. APPROACH: TRDOT measurements were performed in tissue-simulating phantoms, ex vivo tissues, and an in vivo canine prostate model. The accuracy and sensitivity of reconstructing the size and location of the coagulation zone were determined, based on changes in the tissue absorption and reduced scattering coefficients upon photocoagulation. The reconstruction also yields the native and coagulated tissue optical properties. RESULTS: The TRDOT measurements and SBDOT reconstruction algorithm were confirmed to perform sufficiently well for clinical translation in PTT monitoring, recovering the location of the coagulation boundary within ±1 mm compared to the true value as determined by direct visualization postexcision and/or MRI. CONCLUSIONS: Implementing previously described TRDOT instrumentation and SBDOT image reconstruction in different tissue models confirms the potential for clinincal translation, including required refinements of the system and reconstruction algorithm.


Subject(s)
Prostatic Neoplasms , Tomography, Optical , Animals , Dogs , Humans , Male , Phantoms, Imaging , Photothermal Therapy , Prostate/diagnostic imaging , Prostate/surgery , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/therapy , Tomography, Optical/methods
4.
IEEE Trans Biomed Eng ; 67(7): 2119-2129, 2020 07.
Article in English | MEDLINE | ID: mdl-31765300

ABSTRACT

We describe the rationale, design, fabrication and performance of a clinical transrectal diffuse optical tomography (TRDOT) system for in vivo monitoring of photothermal therapy (PTT) of localized prostate cancer. The system comprises a 32-channel fiberoptic-based, MRI-compatible transrectal probe connected to a computer-controlled instrument that includes laser diode sources, an optical fiber switch and photomultiplier tube detectors. Performance tests were performed in tissue-simulating phantoms and in ex vivo muscle tissue during PTT treatment. The safety and technical feasibility of in vivo transrectal use were tested in a canine prostate model and in a first-in-human study in a patient before PTT treatment. Limitations of the system are discussed, as well as further developments to translate it into planned clinical trials for monitoring the photocoagulation boundary in the prostate during PTT.


Subject(s)
Prostatic Neoplasms , Tomography, Optical , Animals , Dogs , Humans , Male , Phototherapy , Photothermal Therapy , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/therapy
5.
PLoS One ; 12(7): e0181654, 2017.
Article in English | MEDLINE | ID: mdl-28759636

ABSTRACT

BACKGROUND: Malignant gliomas are highly invasive, difficult to treat, and account for 2% of cancer deaths worldwide. Glioblastoma Multiforme (GBM) comprises the most common and aggressive intracranial tumor. The study hypothesis is to investigate the modification of Photodynamic Therapy (PDT) efficacy by mild hypothermia leads to increased glioma cell kill while protecting normal neuronal structures. METHODS: Photosensitizer accumulation and PDT efficacy in vitro were quantified in various glioma cell lines, primary rat neurons, and astrocytes. In vivo studies were carried out in healthy brain and RG2 glioma of naïve Fischer rats. Hypothermia was induced at 1 hour pre- to 2 hours post-PDT, with ALA-PpIX accumulation and PDT treatments effects on tumor and normal brain PDT quantified using optical spectroscopy, histology, immunohistochemistry, MRI, and survival studies, respectively. FINDINGS: In vitro studies demonstrated significantly improved post-PDT survival in primary rat neuronal cells. Rat in vivo studies confirmed a neuroprotective effect to hypothermia following PpIX mediated PDT by T2 mapping at day 10, reflecting edema/inflammation volume reduction. Mild hypothermia increased PpIX fluorescence in tumors five-fold, and the median post-PDT rat survival time (8.5 days normothermia; 14 days hypothermia). Histology and immunohistochemistry show close to complete cellular protection in normal brain structures under hypothermia. CONCLUSIONS: The benefits of hypothermia on both normal neuronal tissue as well as increased PpIX fluorescence and RG2 induced rat survival strongly suggest a role for hypothermia in photonics-based surgical techniques, and that a hypothermic intervention could lead to considerable patient outcome improvements.


Subject(s)
Aminolevulinic Acid/pharmacology , Brain Neoplasms/drug therapy , Glioma/drug therapy , Hypothermia, Induced/methods , Photochemotherapy/methods , Protoporphyrins/pharmacology , Animals , Animals, Newborn , Astrocytes/drug effects , Brain/drug effects , Cell Line, Tumor , Cell Survival , Drug Screening Assays, Antitumor , Female , Humans , Magnetic Resonance Imaging , Male , Neurons/drug effects , Photosensitizing Agents/pharmacology , Rats , Rats, Inbred F344 , Rats, Wistar , Temperature
6.
Nanomedicine (Lond) ; 10(1): 89-101, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25046405

ABSTRACT

AIM: As the possibilities of molecular imaging in personalized medicine evolve rapidly, the optical advantages of extremely narrow and intense spectral bands makes surface-enhanced Raman scattering (SERS) an appealing candidate for multiplexed recognition of targeted biomarkers over other optical imaging modalities. MATERIALS & METHODS: In this proof-of-concept study, we report wide-field Raman detection of lung cancer using multimodal SERS nanoprobes specific to the EGF receptor family, both in vitro and in vivo. RESULTS: For the first time, we demonstrate wide-field multiplexed Raman imaging for cancer detection in vivo after topical application of a 'cocktail' of SERS nanoprobes. CONCLUSION: This advancement represents a key step towards sensitive wide-field Raman endoscopic imaging of multiple biomarkers for early and accurate diagnosis of EGF receptor-expressing tumors of different internal organs.


Subject(s)
Diagnostic Imaging , ErbB Receptors/biosynthesis , Lung Neoplasms/diagnostic imaging , Spectrum Analysis, Raman , Animals , Cell Line, Tumor , ErbB Receptors/genetics , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Mice , Radiography , Surface Properties
7.
Lasers Surg Med ; 45(7): 460-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24037824

ABSTRACT

Effective therapies for malignant gliomas are still elusive and limited survival improvements are provided only by Temozolomide or fluorescence guided resection. The efficacy of photodynamic therapy (PDT) in this indication is limited by the higher sensitivity of normal brain structures compared to glioma necessitating a modulation of its sensitivity. We evaluate the influence of hypothermia and the tyrosine kinase inhibitor Erlotinib on cell's ability to synthesize PPIX following the administration of ALA which was not previously investigated. We demonstrate that both hypothermia and Erlotinib are favorable in PPIX selectivity as only glioma cell lines demonstrate an increased PPIX synthesis, whereas the neuronal and astrocytic synthesis is remaining unaffected. The results are encouraging to consider hypothermia and Erlotinib as adjuvant therapies to increase the PDT therapeutic index between GBM and normal intracranial tissues, as well as to improve contrast in fluorescence guided resection.


Subject(s)
Glioblastoma/drug therapy , Hypothermia, Induced , Photochemotherapy/methods , Photosensitizing Agents/pharmacokinetics , Protein Kinase Inhibitors/pharmacology , Protoporphyrins/pharmacokinetics , Quinazolines/pharmacology , Animals , Biomarkers, Tumor/metabolism , Cell Line, Tumor , Cytoplasm/drug effects , Cytoplasm/metabolism , Erlotinib Hydrochloride , Glioblastoma/metabolism , Humans , Mitochondria/drug effects , Mitochondria/metabolism , Photosensitizing Agents/pharmacology , Photosensitizing Agents/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Protoporphyrins/pharmacology , Protoporphyrins/therapeutic use , Quinazolines/therapeutic use , Rats , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...